Compare Epidural vs. Lumbar Plexus Analgesia After Hip Arthroplasty
Compare Effectiveness of Epidural vs. Lumbar Plexus Blocks in Total Hip Arthroplasty (THA) Patients Using Multimodal Pain Control
1 other identifier
observational
116
1 country
1
Brief Summary
The goal of this retrospective chart review is to evaluate if the implementation of lumbar plexus block placement for postoperative pain have improved conditions in the postoperative period for patients undergoing total hip arthroplasty when compared to the placement of epidurals for postoperative pain management.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Dec 2014
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2015
CompletedFirst Submitted
Initial submission to the registry
July 2, 2015
CompletedFirst Posted
Study publicly available on registry
July 9, 2015
CompletedResults Posted
Study results publicly available
March 22, 2019
CompletedMarch 22, 2019
June 1, 2018
6 months
July 2, 2015
June 4, 2018
December 19, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Opiate Consumption
Cumulative opiate consumption in intravenous (IV) morphine mg equivalents (MME)
48 hours postoperative
Secondary Outcomes (1)
Time of First Ambulation
48 hours
Study Arms (2)
Lumbar plexus
Patients received a preoperative lumbar plexus nerve block (20 ml, ropivacaine 0.5%) for postoperative pain management.
Lumbar Epidural
Patients received a lumbar epidural preoperatively for postoperative pain management. Epidural infusions of ropivacaine 0.2% were initiated intraoperatively, administered until the morning of postoperative day 1, and titrated to patient comfort.
Eligibility Criteria
The study team will identify subject by the Primary Diagnosis of THA, (identified by CPT code 27130) and 2) either a) Epidural (CPT code 62319) or b) Lumbar plexus peripheral nerve block (CPT 62311 or 64449) with the administration of multimodal medication.
You may qualify if:
- years and older
- Diagnosis of:
- Primary THA, (identified by CPT code 27130)
- Either a) Epidural (CPT code 62319) or b) Lumbar plexus peripheral nerve block (CPT 62311 or 64449)
- Perioperative multimodal medication
- Hospitalized from July 1, 2012 to December 17, 2014.
You may not qualify if:
- THA Revision
- ICU admission postoperatively
- History of dementia
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Medical University of South Carolina
Charleston, South Carolina, 29425, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Sylvia Wilson
- Organization
- MUSC
Study Officials
- PRINCIPAL INVESTIGATOR
Sylvia Wilson, MD
Medical University of South Carolina
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
July 2, 2015
First Posted
July 9, 2015
Study Start
December 1, 2014
Primary Completion
June 1, 2015
Study Completion
July 1, 2015
Last Updated
March 22, 2019
Results First Posted
March 22, 2019
Record last verified: 2018-06